131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumors
F Grünwald, S Ezziddin - Seminars in nuclear medicine, 2010 - Elsevier
Treatment with 131I-metaiodobenzylguanidine (MIBG) has been introduced to the
management of neuroendocrine tumors (NET) nearly 30 years ago. It provides efficient …
management of neuroendocrine tumors (NET) nearly 30 years ago. It provides efficient …
PET/CT imaging of neuroendocrine tumors with 68Gallium-labeled somatostatin analogues: an overview and single institutional experience from India
Neuroendocrine tumors (NETs) are rare neoplasms characterized by overexpression of
somatostatin receptors (SSTRs). Functional imaging plays a crucial role in management of …
somatostatin receptors (SSTRs). Functional imaging plays a crucial role in management of …
Standard imaging techniques for neuroendocrine tumors
DL Bushnell, RP Baum - Endocrinology and Metabolism Clinics, 2011 - endo.theclinics.com
Several diagnostic imaging techniques including computed tomography (CT), magnetic
resonance imaging (MRI), positron emission tomography (PET)/CT, singlephoton emission …
resonance imaging (MRI), positron emission tomography (PET)/CT, singlephoton emission …
PRRT for higher-grade neuroendocrine neoplasms: What is still acceptable?
G Kong, RJ Hicks - Current opinion in pharmacology, 2022 - Elsevier
Peptide receptor radionuclide therapy (PRRT) is a widely accepted treatment for progressive
grade 1 and 2 (G1-2) gastroenteropancreatic neuroendocrine tumors (NET). There is …
grade 1 and 2 (G1-2) gastroenteropancreatic neuroendocrine tumors (NET). There is …
Imaging hNET reporter gene expression with 124I-MIBG
MA Moroz, I Serganova, P Zanzonico… - Journal of Nuclear …, 2007 - Soc Nuclear Med
The norepinephrine transporter (NET) has recently been suggested as a useful reporter
gene. We have extended this effort by constructing an internal ribosomal entry site (IRES) …
gene. We have extended this effort by constructing an internal ribosomal entry site (IRES) …
Role of Combined 68Ga DOTA-Peptides and 18F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms
C Kaewput, S Vinjamuri - Diagnostics, 2022 - mdpi.com
This review article summarizes the role of combined 68Ga DOTA-peptides and 18F-
fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) …
fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) …
Pancreatic neuroendocrine tumours
N Alexakis, JP Neoptolemos - Best practice & research Clinical …, 2008 - Elsevier
Pancreatic neuroendocrine tumours are rare tumours (∼ 1/100, 00 population/year) of
which 60% are non-functioning. Except for insulinoma all types are malignant in> 50% of …
which 60% are non-functioning. Except for insulinoma all types are malignant in> 50% of …
Response and long-term control of bone metastases after peptide receptor radionuclide therapy with 177Lu-octreotate
S Ezziddin, A Sabet, F Heinemann… - Journal of Nuclear …, 2011 - Soc Nuclear Med
Peptide receptor radionuclide therapy (PRRT) is an efficient treatment for
gastroenteropancreatic neuroendocrine tumors (GEP NETs), with outstanding overall …
gastroenteropancreatic neuroendocrine tumors (GEP NETs), with outstanding overall …
Predictive Value of Asphericity in Pretherapeutic [111In]DTPA-Octreotide SPECT/CT for Response to Peptide Receptor Radionuclide Therapy with [177Lu] …
C Wetz, I Apostolova, IG Steffen, F Hofheinz… - Molecular imaging and …, 2017 - Springer
Purpose The purpose of this study was to assess the value of the spatial heterogeneity of
somatostatin receptor (SSR) volume, quantified as asphericity (ASP), and to predict …
somatostatin receptor (SSR) volume, quantified as asphericity (ASP), and to predict …
An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes
Background: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are
heterogeneous with respect to biological behaviour and prognosis. As angiogenesis is a …
heterogeneous with respect to biological behaviour and prognosis. As angiogenesis is a …